Joon Oh Park

23PUBLICATIONS
193CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Jan 23, 2026
Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years.

Joo-Hyun Park, Jung Yong Hong, Kyungdo Han

|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.

Shubham Pant, Joon Oh Park, Wu-Chou Su

Pageof 4